The significant inhibitory effect of BCDs‐HSA on subcutaneous RM‐1 and B16‐F10 tumors under neutron irradiation also demonstrated the potential of BCDs‐HSA for BNCT on different cancers. This evidence concerns the gene ALB and cancer.